Synthetic cannabinoid poisonings and access to the legal cannabis market: findings from US national poison centre data 2016–2019

References

• Loeffler G, Delaney E, Hann M. International trends in spice use: prevalence, motivation for use, relationship to other substances, and perception of use and safety for synthetic cannabinoids. Brain Res Bull. 2016;126(Pt 1):8–28.
   PubMedGoogle Scholar
• Palamar JJ, Barratt MJ, Coney L, et al. Synthetic cannabinoid use among high school seniors. Pediatrics. 2017;140(4):e20171330.
   PubMed Web of Science ®Google Scholar
• Tamama K, Lynch MJ. Newly emerging drugs of abuse. Handb Exp Pharmacol. 2020;258:463–502.
   PubMedGoogle Scholar
• Winstock AR, Barratt MJ. Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample. Drug Alcohol Depend. 2013;131(1–2):106–111.
   PubMed Web of Science ®Google Scholar
• Ninnemann AL, Lechner WV, Borges A, et al. Synthetic cannabinoids to avoid urine drug screens: implications for contingency management and other treatments for drug dependence. Addict Behav. 2016;63:72–73.
   PubMed Web of Science ®Google Scholar
• 112th United States Congress (2011–2012). S.3190. Synthetic drug abuse prevention act of 2012 (Introduced version). 2012. Available from: https://www.congress.gov/bill/112th-congress/senate-bill/3190/
   Google Scholar
• National Poison Data System, American Association of Poison Control Centers. Synthetic cannabinoids. 2022. Available from: https://aapcc.org/track/synthetic-cannabinoids
   Google Scholar
• Zaurova M, Hoffman RS, Vlahov D, et al. Clinical effects of synthetic cannabinoid receptor agonists compared with marijuana in emergency department patients with acute drug overdose. J Med Toxicol. 2016;12(4):335–340.
   PubMed Web of Science ®Google Scholar
• Malaca S, Tini A, Ronchi U. F. Fourth generation of synthetic cannabinoid receptor agonists: a summary on the latest insights. Acta Biomed. 2022;92(6):e2021546.
   PubMedGoogle Scholar
• Le Boisselier R, Alexandre J, Lelong-Boulouard V, et al. Focus on cannabinoids and synthetic cannabinoids. Clin Pharmacol Ther. 2017;101(2):220–229.
   PubMed Web of Science ®Google Scholar
• Gunderson EW, Haughey HM, Ait-Daoud N, et al. Spice” and “K2” herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans. Am J Addict. 2012;21(4):320–326.
   PubMed Web of Science ®Google Scholar
• Adamowicz P, Meissner E, Maślanka M. Fatal intoxication with new synthetic cannabinoids AMB-FUBINACA and EMB-FUBINACA. Clin Toxicol (Phila). 2019;57(11):1103–1108.
   PubMed Web of Science ®Google Scholar
• Riederer AM, Campleman SL, Carlson RG, et al. Acute poisonings from synthetic cannabinoids - 50 US toxicology investigators consortium registry sites, 2010–2015. MMWR Morb Mortal Wkly Rep. 2016;65(27):692–695.
   PubMed Web of Science ®Google Scholar
• Choi NG, Marti CN, DiNitto DM, et al. Cannabis and synthetic cannabinoid poison control center cases among adults aged 50+, 2009-2019. Clin Toxicol (Phila). 2021;59(4):334–342.
   PubMed Web of Science ®Google Scholar
• Roehler DR, Hoots BE, Vivolo-Kantor AM. Regional trends in suspected synthetic cannabinoid exposure from January 2016 to September 2019 in the United States. Drug Alcohol Depend. 2020;207:107810.
   PubMed Web of Science ®Google Scholar
• Carpenter JE, Chang AS, Bronstein AC, et al. Identifying incidents of public health significance using the national poison data system, 2013–2018. Am J Public Health. 2020;110(10):1528–1531.
   PubMed Web of Science ®Google Scholar
• Gummin DD, Mowry JB, Beuhler MC, et al. 2019 Annual report of the American association of poison control centers’ national poison data system (NPDS): 37th annual report. Clin Toxicol (Phila). 2020;58(12):1360–1541.
   PubMed Web of Science ®Google Scholar
• Tait RJ, Caldicott D, Mountain D, et al. A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Clin Toxicol (Phila). 2016;54(1):1–13.
   PubMed Web of Science ®Google Scholar
• Lake S, Assaf RD, Gorbach PM, et al. Selective changes in medical cannabis use early in the COVID-19 pandemic: findings from a Web-Based sample of adults in the United States. Cannabis Cannabinoid Res. 2022. DOI:10.1089/can.2021.0115
   Google Scholar
• National Conference of State Legislatures. Cannabis overview. 2022. Available from: https://www.ncsl.org/research/civil-and-criminal-justice/marijuana-overview.aspx
   Google Scholar
• Americans for Safe Access. State of the states report 2015–2020. Available from: https://www.safeaccessnow.org/reports_archive
   Google Scholar
• Darke S, Banister S, Farrell M, et al. Synthetic cannabis’: a dangerous misnomer. Int J Drug Policy. 2021;98:103396.
   PubMedGoogle Scholar
• Keyes KM, Rutherford C, Hamilton A, et al. Age, period, and cohort effects in synthetic cannabinoid use among US adolescents, 2011–2015. Drug Alcohol Depend. 2016;166:159–167.
   PubMed Web of Science ®Google Scholar
• Pacula RL, Jacobson M, Maksabedian EJ. In the weeds: a baseline view of cannabis use among legalizing states and their neighbours. Addiction. 2016;111(6):973–980.
   PubMed Web of Science ®Google Scholar